Overview
Dentalcorp Q3 revenue grows 11.9% yr/yr, slightly beating analyst expectations
Adjusted EBITDA for Q3 rises 14.2% yr/yr, reflecting operational growth
Company to be acquired by GTCR LLC for C$2.2 bln equity value
Outlook
Company suspends financial outlook due to acquisition by GTCR LLC
Result Drivers
PRACTICE ACQUISITIONS - Co acquired 13 new practice locations, contributing to revenue growth
RECURRING PATIENT VISITS - Achieved a 90.3% recurring patient visit rate, indicating strong demand
CDCP IMPACT - Treated over 135,000 CDCP patients, integrating the plan into operations
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Slight Beat*
C$420.10 mln
C$417 mln (11 Analysts)
Q3 Adjusted Net Income
C$28.80 mln
Q3 Adjusted EBITDA
C$78.70 mln
Q3 Adjusted EBITDA Margin
18.70%
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 4 "strong buy" or "buy", 4 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy."
Wall Street's median 12-month price target for dentalcorp Holdings Ltd is C$11.00, about 0.8% above its November 5 closing price of C$10.91
The stock recently traded at 22 times the next 12-month earnings vs. a P/E of 15 three months ago
Press Release: ID:nBw59DzTla
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)